Warfarin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin
Condition:   Rectus Sheath Hematoma Formation Following Cesarean Section Intervention:   Drug: Tranexamic acid Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data
Condition:   Non-valvular Atrial Fibrillation Interventions:   Drug: Warfarin;   Drug: Apixaban Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin
Condition:   Rectus Sheath Hematoma Formation Following Cesarean Section Intervention:   Drug: Tranexamic acid Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data
Condition:   Non-valvular Atrial Fibrillation Interventions:   Drug: Warfarin;   Drug: Apixaban Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin
Condition:   Rectus Sheath Hematoma Formation Following Cesarean Section Intervention:   Drug: Tranexamic acid Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data
Condition:   Non-valvular Atrial Fibrillation Interventions:   Drug: Warfarin;   Drug: Apixaban Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin
Condition:   Rectus Sheath Hematoma Formation Following Cesarean Section Intervention:   Drug: Tranexamic acid Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data
Condition:   Non-valvular Atrial Fibrillation Interventions:   Drug: Warfarin;   Drug: Apixaban Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin
Condition:   Rectus Sheath Hematoma Formation Following Cesarean Section Intervention:   Drug: Tranexamic acid Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data
Condition:   Non-valvular Atrial Fibrillation Interventions:   Drug: Warfarin;   Drug: Apixaban Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin
Conditions:   Rectus Sheath Hematoma;   Cesarean Section Intervention:   Drug: Tranexamic acid Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data
Condition:   Non-valvular Atrial Fibrillation Interventions:   Drug: Warfarin;   Drug: Apixaban Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin
Conditions:   Rectus Sheath Hematoma;   Cesarean Section Intervention:   Drug: Tranexamic acid Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data
Condition:   Non-valvular Atrial Fibrillation Interventions:   Drug: Warfarin;   Drug: Apixaban Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials

TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin
Conditions:   Rectus Sheath Hematoma;   Cesarean Section Intervention:   Drug: Tranexamic acid Sponsor:   Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2022 Category: Research Source Type: clinical trials